Danone involved in Chinese bribery claim

<p>A Chinese bribery claim has engulfed Danone.</p>

A brand owned by French company Danone has been accused of being involved in a bribery scandal in China.

Dumex is accused of having paid doctors and nurses in the northern city of Tianjin to promote its baby formula products, China Central Television reported.

But these claims were quickly denied by a Dumex spokeswoman, who stated that the firm was "extremely shocked" by the allegations.

She added: "Dumex Baby Food Co strictly adheres to Chinese laws and regulations."

The Chinese government is currently cracking down on corruption within the healthcare sector.

It is claimed that Danone's Dumex brand paid hospital staff  "sponsorship fees" or payments of up to 10,000 yuan (£1,027).

However, the share price of Danone appears to be unaffected by these claims today (September 17th), with stocks in the firm increasing in value.

At 15:34 BST, its shares were selling 0.64 per cent higher than at the start of the day.

Learn about the Asian markets and CFD trading at City Index

Build your confidence risk free
Join our live webinars for the latest analysis and trading ideas. Register now

StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.